ASSESSING TREATMENT BENEFIT IN IMMUNO-ONCOLOGY
October 26, 2021
This webinar was presented by Laurence Collette, MSc, PhD, Principal Statistician, Consulting Services at IDDI at the 5th Annual Next…
Resources
Resources
Free Resources Library related to clinical trial innovation : Discover our recorded webinars, service flyers, experience, white papers and more related to clinical development.
Phase I trials in oncology: Pros and cons of current designs
October 21, 2021
Demystifying different types of Bayesian and frequentist designs that may be used for first-in-human or other types of phase I…
Sample Size Re-Estimation as an Adaptive Design
Using the promising-zone approach can salvage an underpowered trial. Sample size Re-estimation (SSRE) is a relatively new concept, but, thanks…
Operational characteristics of generalized pairwise comparisons for hierarchically ordered endpoints
Vaiva Deltuvaite-Thomas, Research Statistician, IDDI and Prof. Tomasz Burzykowski, VP Research IDDI have just published an article on operational characteristics…
Immunotherapy against cancer: Challenge and opportunities
With some of the recently developed drugs showing unprecedented response rates and consistent improvement in overall survival in some indications,…
Biostatistics and SARS-CoV-2: research, policymaking, and communication
September 21, 2021
Learn on the central role of Biostatistics in the COVID-19 Pandemia, and the multidisciplinary nature of pandemic response LISTEN TO…
Webinar: Randomization and the Limits of Precision Oncology
August 26, 2021
WATCH RECORDED WEBINAR Drug development in oncology is undergoing several changes brought about by precision medicine, which makes it appealing…
Drug Development in Oncology in the Era of Precision Medicine
Cancer research is complex: trials require specific design expertise and often include biomarker and companion diagnostics, and failure rates tend…
The Importance of Early Phase Trials in Precision Oncology
Nowadays, drug development in oncology is largely centered on the basic premise of precision medicine, according to which targeted agents…
Considerations on the mechanics and sample sizes for early trials of targeted agents and immunotherapy in oncology
Read article on trial design and sample sizes for early trials Written by Elisabeth Coart and Everardo D. Saad, Consulting…